Phase 2 study of ibrutinib in relapsed or refractory mantle cell lymphoma: updated safety analysis on prevalence of infection, diarrhea, and bleeding over time
2014
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI